Silence Therapeutics (SLN) Q4 2023 Earnings

13MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.18
-0.12
-0.06
0

Details

Expected EPS
-0.026909947
Actual EPS
-0.052616909
Surprise EPS
-0.03
Surprise Percent
+95.53%

Description

Silence Therapeutics (SLN) has reported earnings of -0.052616909 per share for Q4 2023.

0 Comments

Share your thoughts